12.3 Institutional, Automated Dispensing & Central-Fill Operations

12.3 Institutional, Automated Dispensing & Central-Fill Operations

Modern pharmacy practice encompasses specialized institutional settings, automated technology, and distributed shared-service workflows. In the Commonwealth of Kentucky, administrative regulations establish rigorous standards for hospital pharmacy governance (201 KAR 2:074), automated dispensing systems (201 KAR 2:045), central fill and shared services processing (201 KAR 2:205), and the formal legal procedures for the permanent closure of a pharmacy (201 KAR 2:106).

1. Institutional & Hospital Pharmacy Operations (201 KAR 2:074)

An Institutional Pharmacy is defined as a pharmacy located within a hospital, inpatient medical center, sanitarium, or nursing facility providing inpatient and outpatient healthcare services. It operates under a specialized Institutional Pharmacy Permit issued by the Kentucky Board of Pharmacy.

Director of Pharmacy (Institutional PIC)

• Every institutional pharmacy must be directed by a Kentucky-licensed pharmacist designated as the Director of Pharmacy (PIC).
• The Director is legally responsible for the safe and efficient distribution, compounding, labeling, control, storage, and accountability of all drugs throughout the entire institution, including off-site surgical suites, ambulatory clinics, and nursing care units.

24-Hour Coverage & After-Hours Medication Access Protocols

Hospitals must strive to provide continuous 24-hour on-site pharmacist coverage. However, when 24-hour physical pharmacist presence is not feasible, the Director of Pharmacy must establish formal, Board-compliant after-hours access procedures:

┌─────────────────────────────────────────────────────────────────────────────┐
│                  HOSPITAL AFTER-HOURS MEDICATION ACCESS                     │
├─────────────────────────────────────┬───────────────────────────────────────┤
│ Night Cabinets / Emergency Lockers  │ Emergency Medication Boxes (EMBs)     │
│ • Located outside physical pharmacy │ • Located in patient care nursing units│
│ • Access: Supervisory RN ONLY       │ • Tamper-evident numbered seal        │
│ • Pre-packaged, labeled unit doses  │ • Crash carts / stat emergency supply │
│ • Pharmacist review <= 24 HOURS     │ • Box Exp Date = Earliest Drug Exp    │
└─────────────────────────────────────┴───────────────────────────────────────┘

1. Night Cabinets / Secure After-Hours Enclosures:
   • Physical Enclosure: A locked, secure cabinet or automated unit located outside the physical pharmacy department.
   • Access Restrictions: Only authorized supervisory registered nurses (RNs) designated in writing by the hospital may access the night cabinet when the pharmacy is closed.
   • Inventory Scope: Stored medications are limited to pre-packaged, properly labeled unit doses on an approved formulary list necessary for immediate therapeutic care.
   • Documentation: The RN accessing the cabinet must record: (1) patient name and room number, (2) drug name, strength, and dosage form, (3) quantity removed, (4) date and time of removal, and (5) RN signature/electronic ID.
   • Mandatory 24-Hour Pharmacist Review: A Kentucky-licensed pharmacist must review, verify, and reconcile all night cabinet access transactions and medical orders within twenty-four (24) hours of pharmacy opening.
2. Emergency Pharmacy Access (Physician/RN Entry Prohibited):
   • Non-pharmacist healthcare personnel (including physicians, nurses, and hospital administrators) are strictly prohibited from entering the closed institutional pharmacy department unaccompanied. If an emergency drug is needed that is not in a night cabinet or emergency kit, an on-call Kentucky-licensed pharmacist must be called in to dispense the drug.
3. Emergency Medication Boxes (EMBs) & Crash Carts:
   • Secure, tamper-evidently sealed kits placed in patient care areas and long-term care facilities for acute resuscitation or emergency therapy.
   • Expiration Dating: The expiration date of the entire Emergency Medication Box is determined by the EARLIEST expiration date of any individual medication component contained inside the box.
   • Resealing & Restocking: Once the tamper-evident seal is broken, the kit must be returned immediately to the pharmacy for complete inspection, restocking, and resealing by pharmacy personnel.

2. Automated Dispensing Systems (ADCs) in Healthcare Facilities (201 KAR 2:045, 2:074)

Automated Dispensing Cabinets (ADCs)—such as Pyxis MedStation, Omnicell, and BD systems—are computerized medication storage and distribution devices deployed across hospital nursing units, intensive care units, and long-term care facilities.

Prospective Drug Utilization Review (DUR) Mandate

• General Rule: Under 201 KAR 2:045 and 201 KAR 2:074, a licensed pharmacist must prospectively review and approve the medication order before the ADC will release the medication for administration to a patient.
• Emergency Override Exception: An authorized nurse may remove medication from the ADC prior to prospective pharmacist review ONLY under a formal Emergency Override Protocol:
  • The Pharmacy and Therapeutics (P&T) committee must establish a strictly limited, written list of emergency override medications (e.g., naloxone, atropine, epinephrine, dextrose 50%, nitroglycerin, acute analgesics).
  • The override may be utilized only when waiting for pharmacist prospective review would severely jeopardize patient health.
  • Daily Retrospective Audit: All emergency override access transactions must be reviewed and audited by a pharmacist daily (within 24 hours).

Stocking, Restocking & Quality Assurance Controls

• Technician Stocking & Barcode Verification: Registered pharmacy technicians may restock ADCs provided the system utilizes electronic barcode scanning verification (scanning the drug package barcode and the ADC bin barcode) or restocking occurs under the direct supervision and physical inspection of a licensed pharmacist.
• Controlled Substance Discrepancy Reconciliation: Controlled substances stored in ADCs must undergo perpetual electronic tracking. Shift-to-shift physical counts must be reconciled, and any unresolved discrepancies must be reported immediately to the Director of Pharmacy and investigated.
• Record Retention: Electronic transaction logs, override reports, access records, and maintenance logs must be maintained and retrievable for five (5) years under Kentucky law.

3. Central Fill & Shared Pharmacy Services (201 KAR 2:205)

Under 201 KAR 2:205, Kentucky permits licensed pharmacies to enter into shared pharmacy service and central fill arrangements to optimize dispensing efficiency, provided strict consumer protection and accountability standards are maintained.

Definitions & Structural Relationships

• Originating Pharmacy: The community or institutional pharmacy that receives the original prescription order directly from the patient or prescriber and dispenses the finished product to the patient.
• Central Fill Pharmacy: A permitted pharmacy that fills, compounds, packages, or processes prescription orders on behalf of an originating pharmacy pursuant to an authorized agreement.
• Prerequisites for Operation: Originating and Central Fill pharmacies must either: (1) be under common ownership; or (2) operate under a formal written contract detailing the specific shared responsibilities and audit mechanisms of each entity. Both facilities must share a real-time, bidirectional electronic database.

Division of Responsibilities & Workflow

Central Fill for Controlled Substances (21 CFR § 1306.15 & Kentucky Rules)

Controlled substance prescriptions (Schedules II, III, IV, and V) may be transmitted to a central fill pharmacy electronically or via facsimile:

• The originating pharmacy must write "CENTRAL FILL" on the face of the original prescription (or tag the electronic record) and record: (1) central fill pharmacy name, address, and DEA registration number; (2) transmitting pharmacist ID; and (3) date of transmission.
• The central fill pharmacy must maintain a complete log of all controlled substances received, filled, verified, and shipped back to the originating pharmacy.
• Both pharmacies remain jointly accountable for verifying legitimate medical purpose and maintaining records for 5 years.

4. Permanent Closure of a Pharmacy in Kentucky (201 KAR 2:106)

The permanent cessation of pharmacy operations is strictly regulated to prevent drug abandonment, protect patient medication records, and safeguard controlled substance supply chains.

┌─────────────────────────────────────────────────────────────────────────────┐
│                 PERMANENT PHARMACY CLOSURE: 14-DAY PROTOCOL                 │
├─────────────────────────────────────┬───────────────────────────────────────┤
│ 14 Days BEFORE Closing:             │ • Written notice to KBOP, DEA & CHFS  │
│                                     │ • Post entrance notice (stay 30 days) │
│                                     │ • Publish notice in local newspaper   │
├─────────────────────────────────────┼───────────────────────────────────────┤
│ ON the Closing Day:                 │ • Exact C-II to C-V physical inventory│
│                                     │ • Transfer C-II via DEA Form 222      │
│                                     │ • Transfer C-III-V/Rx files (5-yr rule│
├─────────────────────────────────────┼───────────────────────────────────────┤
│ WITHIN 14 Days AFTER Closing:       │ • Surrender KY Permit to KBOP         │
│                                     │ • Surrender DEA Cert & Form 222s      │
│                                     │ • Remove all 'Pharmacy' signage       │
└─────────────────────────────────────┴───────────────────────────────────────┘

Detailed Closing Day Operational Requirements (201 KAR 2:106)

1. Fifteen-Day Multi-Agency Written Notice:
   • Under 201 KAR 2:106, written notice of a permanent voluntary closure must be given fifteen (15) days prior to the anticipated closing date to: (1) KBOP, (2) DEA, and (3) CHFS. (An involuntary closure — fire, flood, loss of the pharmacist-in-charge, condemnation — must instead be reported within five (5) days of the event, with lawful transfer of drugs arranged within sixty (60) days after the effective date of closure.)
   • Notice must specify: (a) proposed closing date, (b) name, address, permit/DEA numbers of closing pharmacy, (c) name, address, permit/DEA numbers of recipient pharmacy acquiring prescription records and drug inventory, and (d) physical address where closed pharmacy records will be maintained for 5 years.
2. Public Notice Mandates:
   • On-Site Posting: A bold notice must be posted conspicuously at all public entrances at least 14 days before closing and must remain posted for at least 30 days after closure, informing the public where prescription records have been transferred.
   • Newspaper Publication: Publish a legal notice in the local newspaper of largest circulation in the county at least 14 days prior to closing.
3. Closing Day Controlled Substance Inventory & Transfer:
   • Take a complete, exact physical inventory of all Schedule II, III, IV, and V controlled substances on the final day of business.
   • Schedule II Transfer: The acquiring pharmacy must execute and issue an official DEA Form 222 (or CSOS order) to the closing pharmacy as the supplier.
   • Schedule III–V Transfer: Executed via commercial invoice documenting drug name, dosage form, strength, quantity, and date.
4. Custody of Prescription Files & 5-Year Maintenance:
   • Active prescription files, patient profiles, and transaction logs are transferred to the acquiring permitted pharmacy. All transferred records must be maintained and retrievable for five (5) years.
5. Surrender of Permits & Signage Removal:
   • Within 14 days following closure, the physical Kentucky Pharmacy Permit must be surrendered to the Board, and the DEA Certificate of Registration and unused DEA 222 forms returned to the DEA.
   • All exterior and interior signs containing the words "Pharmacy", "Prescriptions", "Apothecary", "Drugs", or "Medicine" must be completely removed.